About Taxol Injection
Paclitaxel injection usp 100 mg/30 mg is shown as first-line and resulting treatment for the treatment of cutting edge carcinoma of the ovary. As first-line treatment, paclitaxel injection, usp is shown in mix with cisplatin. Paclitaxel injection, usp is shown for the adjuvant treatment of hub positive bosom tumor managed successively to standard doxorubicin-containing blend chemotherapy.- 3s organization is exporter, supplier, wholesaler for paclitaxel injection usp 100 mg/30 mg in india.
- India has numerous makers who make paclitaxel injection usp 100 mg/30 mg .To Know more get in touch with us.
Additional information :Bone marrow concealment (basically neutropenia) is measurements subordinate and is the dosage restricting poisonous quality. Neutrophil nadirs happened at a middle of 11 days. Paclitaxel injection ought not be directed to patients with pattern neutrophil checks of under 1500 cells/mm3 (< 1000 cells/mm3 for patients with ks). Visit checking of blood tallies ought to be established amid paclitaxel injection treatment.Indications :- Call specialist immediately if quiet has a severe symptom, for example, Fever, chills, body hurts, influenza side effects, wounds in mouth and throat;
- Fair skin, feeling dizzy or shy of breath, fast heart rate, inconvenience concentrating;
- Simple wounding, bizarre dying (nose, mouth, or rectum), purple or red pinpoint spots under your skin;
- Bleeding (warmth, redness).
Precise Antineoplastic TherapyTaxol Injection delivers targeted anti-cancer treatment for multiple malignancies, leveraging the proven efficacy of paclitaxel. Used in hospitals and clinics, it provides benefits as part of allopathic therapies aimed at improving patient outcomes in advanced or metastatic cancers.
Safe and Effective AdministrationAdministered as an intravenous infusion, Taxol Injection must be delivered by trained healthcare professionals. For optimal safety, non-PVC administration sets and in-line filters are recommended, ensuring both patient welfare and drug compatibility during infusion.
Versatile Packaging and StorageThis product comes in different volumetric strengths to suit individualized dosing needs. The sterile glass vial ensures stability and ease of handling. To preserve quality, store the injection below 25C and away from light, offering a shelf life of up to two years.
FAQs of Taxol Injection:
Q: How is Taxol Injection administered to patients?
A: Taxol Injection is given by intravenous infusion, typically in hospital, clinic, or under physician supervision. It should be administered using non-PVC sets and filters to ensure compatibility and patient safety.
Q: What conditions is Taxol Injection indicated for?
A: Taxol Injection is indicated primarily for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposis sarcoma. Physicians may also prescribe it for other uses where paclitaxels antineoplastic properties are beneficial.
Q: When should Taxol Injection be used, and who can receive it?
A: Taxol Injection is a prescription-only medication for adult patients, administered based on a physicians direction. Usage timing and dosage are determined after evaluating individual cancer type and patient health status.
Q: Where should Taxol Injection be stored to maintain its shelf life?
A: The vials should be kept below 25C and protected from light. Appropriate storage helps preserve its sterility and effectiveness for up to two years.
Q: What is the process for preparing and administering Taxol Injection?
A: Healthcare professionals prepare Taxol Injection for infusion, ensuring the use of compatible non-PVC equipment and in-line filters. The dosage is as prescribed, and the solution should be clear and free from visible particles before use.
Q: What are the benefits of using Taxol Injection in cancer treatment?
A: Taxol Injection offers potent antineoplastic action by targeting and interfering with cancer cell division. It is proven to improve outcomes for several advanced cancers when used as part of comprehensive therapy.